Literature DB >> 804437

Effect on primary Rh immunization of delayed administration of anti-Rh.

D Samson, P L Mollison.   

Abstract

An intramuscular injection of 100 mug of anti-Rh, given 13 days after an intravenous injection of 1 ml of Rh-positive red cells appeared to suppress primary Rh immunization: at 6 months, none of thirteen subjects so treated had detectable anti-Rh in their plasma, whereas anti-Rh was present in five out of twelve control subjects injected with Rh-positive cells alone (P equals 0.015, Fisher's exact test, one-tailed). Primary immunization was not suppressed in all treated subjects since, following a second injection of Rh-positive cells, 7-day survival was subnormal in three subjects, all of whom had anti-Rh in their plasma after a further 2 weeks. In three other treated subjects, primary Rh immunization appeared to be completely suppressed: survival was normal, or initially normal, following a second injection of Rh-positive cells and anti-Rh was detectable only after a third injection.

Mesh:

Substances:

Year:  1975        PMID: 804437      PMCID: PMC1445805     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  11 in total

1.  Immunization after intravenous injection of small amounts of 51Cr-labelled red cells.

Authors:  P L ADNER; S FOCONI; S SJOLIN
Journal:  Br J Haematol       Date:  1963-07       Impact factor: 6.998

2.  HAEMOLYTIC DISEASE AND THE RHESUS GENOTYPES.

Authors:  S MURRAY; G KNOX; W WALKER
Journal:  Vox Sang       Date:  1965 May-Jun       Impact factor: 2.144

3.  The effect of Rh genotypes on severity in haemolytic disease of the newborn.

Authors:  S MURRAY
Journal:  Br J Haematol       Date:  1957-04       Impact factor: 6.998

4.  Improved method of labelling red cells with radioactive phosphorus.

Authors:  P L MOLLISON; M A ROBINSON; D A HUNTER
Journal:  Lancet       Date:  1958-04-12       Impact factor: 79.321

5.  Regulation of the immune response. VI. Inability of F(ab') 2 antibody to terminate established immune responses and its ability to interfere with IgG antibody-mediated immunosuppression.

Authors:  P L Chan; N R Sinclair
Journal:  Immunology       Date:  1973-02       Impact factor: 7.397

6.  Clearance of Rh-positive red cells by low concentrations of Rh antibody.

Authors:  P L Mollison; N C Hughes-Jones
Journal:  Immunology       Date:  1967-01       Impact factor: 7.397

7.  Suppression of primary RH immunization by passively-administered antibody. Experiments in volunteers.

Authors:  P L Mollison; N C Hughes-Jones; M Lindsay; J Wessely
Journal:  Vox Sang       Date:  1969-04       Impact factor: 2.144

8.  Immunization of Rh-negative volunteers by repeated injections of very small amounts of Rh-positive blood.

Authors:  R Jakobowicz; L Williams; F Silberman
Journal:  Vox Sang       Date:  1972       Impact factor: 2.144

9.  Studies on Rh prophylaxis. II. Rh immune prophylaxis after transfusion with Rh-positive blood.

Authors:  W Pollack; W Q Ascari; J F Crispen; R R O'Connor; T Y Ho
Journal:  Transfusion       Date:  1971 Nov-Dec       Impact factor: 3.157

10.  Differences between Rh(D) negative subjects in response to Rh(D) antigen.

Authors:  P L Mollison; M Frame; M E Ross
Journal:  Br J Haematol       Date:  1970-08       Impact factor: 6.998

View more
  6 in total

1.  Prevention of Rh haemolytic disease.

Authors:  L A Tovey; J Murray; B J Stevenson; J M Taverner
Journal:  Br Med J       Date:  1978-07-08

2.  Recommendations for the prevention and treatment of haemolytic disease of the foetus and newborn.

Authors:  Francesco Bennardello; Serelina Coluzzi; Giuseppe Curciarello; Tullia Todros; Stefania Villa
Journal:  Blood Transfus       Date:  2015-01       Impact factor: 3.443

3.  Suppression of the secondary immune response by specific antibody, when given together with the secondary antigenic stimulus.

Authors:  H Finger; H Hof; C H Wirsing; P Emmerling
Journal:  Experientia       Date:  1977-04-15

4.  The prevention of rh-immunization.

Authors:  J M Bowman
Journal:  Can Fam Physician       Date:  1977-12       Impact factor: 3.275

Review 5.  Examining the Role of Complement in Predicting, Preventing, and Treating Hemolytic Transfusion Reactions.

Authors:  Connie M Arthur; Satheesh Chonat; Ross Fasano; Marianne E M Yee; Cassandra D Josephson; John D Roback; Sean R Stowell
Journal:  Transfus Med Rev       Date:  2019-10-18

Review 6.  Initiation and regulation of complement during hemolytic transfusion reactions.

Authors:  Sean R Stowell; Anne M Winkler; Cheryl L Maier; C Maridith Arthur; Nicole H Smith; Kathryn R Girard-Pierce; Richard D Cummings; James C Zimring; Jeanne E Hendrickson
Journal:  Clin Dev Immunol       Date:  2012-10-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.